Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,212 | 613 | 59.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,156 | 6 | 40.7% |
| Travel and Lodging | $57.93 | 2 | 0.2% |
| Education | $1.13 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $14,982 | 165 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,314 | 23 | $0 (2023) |
| Allergan, Inc. | $1,245 | 78 | $0 (2022) |
| Biogen, Inc. | $983.90 | 17 | $0 (2024) |
| EMD Serono, Inc. | $866.03 | 18 | $0 (2024) |
| Lundbeck LLC | $819.84 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $776.18 | 17 | $0 (2024) |
| PFIZER INC. | $741.20 | 31 | $0 (2024) |
| Amgen Inc. | $408.90 | 18 | $0 (2024) |
| ARGENX US, INC. | $404.03 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,826 | 145 | ABBVIE INC. ($7,806) |
| 2023 | $8,127 | 146 | AbbVie Inc. ($6,013) |
| 2022 | $2,792 | 110 | ABBVIE INC. ($752.23) |
| 2021 | $2,232 | 108 | Allergan, Inc. ($460.26) |
| 2020 | $539.90 | 25 | Allergan, Inc. ($235.51) |
| 2019 | $1,079 | 33 | Novartis Pharmaceuticals Corporation ($516.39) |
| 2018 | $826.64 | 27 | Allergan Inc. ($304.08) |
| 2017 | $2,004 | 28 | Teva Pharmaceuticals USA, Inc. ($895.97) |
All Payment Transactions
622 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/14/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $28.47 | General |
| 12/10/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/03/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: PAIN | ||||||
| 11/25/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Analgesic | ||||||
| 11/22/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| 11/15/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $90.42 | General |
| Category: PAIN | ||||||
| 11/15/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $70.22 | General |
| Category: PAIN | ||||||
| 11/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $68.42 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | Tonix Medicines, Inc. | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $100.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $1.94 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $1.19 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.81 | General |
| Category: NEUROLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.98 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 639 | 12,745 | $1.3M | $141,548 |
| 2022 | 10 | 544 | 15,756 | $621,581 | $160,895 |
| 2021 | 11 | 461 | 17,818 | $598,415 | $156,544 |
| 2020 | 11 | 401 | 12,928 | $466,875 | $116,276 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 67 | 11,955 | $392,101 | $58,948 | 15.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 176 | $215,600 | $19,604 | 9.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 53 | 99 | $155,826 | $15,222 | 9.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 142 | 169 | $148,382 | $13,892 | 9.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 38 | 81 | $65,610 | $7,213 | 11.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 64 | 64 | $70,784 | $6,755 | 9.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 62 | 76 | $54,720 | $6,370 | 11.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 25 | 28 | $57,680 | $5,308 | 9.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $53,580 | $3,873 | 7.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 16 | 43 | $23,177 | $2,431 | 10.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 12 | 27 | $18,657 | $1,930 | 10.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 49 | 15,022 | $267,549 | $73,429 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 183 | $97,425 | $20,320 | 20.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 80 | 92 | $48,800 | $15,437 | 31.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 51 | 113 | $40,020 | $10,938 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 68 | 68 | $43,090 | $10,288 | 23.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 120 | $42,633 | $10,245 | 24.0% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 29 | 55 | $40,195 | $8,782 | 21.8% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 33 | 37 | $25,560 | $7,610 | 29.8% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 24 | 49 | $12,144 | $2,583 | 21.3% |
| 95873 | Electrical stimulation for guidance with injection of chemical for paralysis of nerve muscle | Office | 2022 | 11 | 17 | $4,165 | $1,263 | 30.3% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 35 | 17,204 | $344,060 | $83,541 | 24.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 136 | 207 | $78,660 | $23,657 | 30.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 105 | 105 | $60,900 | $16,132 | 26.5% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2021 | 20 | 56 | $32,760 | $9,218 | 28.1% |
About Jennifer Ahmed
Jennifer Ahmed is a Neurology healthcare provider based in Plainview, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1619139201.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Ahmed has received a total of $27,427 in payments from pharmaceutical and medical device companies, with $9,826 received in 2024. These payments were reported across 622 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($16,212).
As a Medicare-enrolled provider, Ahmed has provided services to 2,045 Medicare beneficiaries, totaling 59,247 services with total Medicare billing of $575,263. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Plainview, NY
- Active Since 06/25/2008
- Last Updated 12/28/2011
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1619139201
Products in Payments
- QULIPTA (Drug) $11,038
- UBRELVY (Drug) $3,039
- BOTOX (Biological) $1,771
- COPAXONE (Drug) $868.45
- VYEPTI (Biological) $819.84
- NURTEC ODT (Drug) $665.66
- MAYZENT (Drug) $413.28
- Briviact (Drug) $249.68
- AJOVY (Drug) $232.04
- Wakix (Drug) $221.87
- ZINBRYTA (Biological) $218.92
- VYVGART (Drug) $216.53
- Rebif (Biological) $207.09
- BOTOX - NEUROLOGY (Drug) $206.33
- Mavenclad (Biological) $198.61
- ACTIVA (Device) $197.68
- Xeomin (Biological) $193.34
- TECFIDERA (Drug) $189.82
- UPLIZNA (Drug) $188.19
- VYVGART HYTRULO (Drug) $187.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Plainview
Dr. Stephen Newman, M.d, M.D
Neurology — Payments: $1.2M
Dr. Ira Turner, M.d, M.D
Neurology — Payments: $865,285
Dr. John Kelemen, M.d, M.D
Neurology — Payments: $168,048
Dr. Erik Entin, M.d, M.D
Neurology — Payments: $4,988
Dr. Vandana Soni, M.d, M.D
Neurology — Payments: $2,106
Dr. Michael Gruttadauria, Dc, Dacan, DC, DACAN
Neurology — Payments: $10.79